by Mrudula Kulkarni
1 minutes
Patrik Strömberg Joins AAX Biotech Board, Bringing Extensive Pharma Experience
Patrik Strömberg joins AAX Biotech's board, bringing 20+ years of pharmaceutical industry experience.
Image Source: https://news.cision.com/aax-biotech-ab/r/aax-biotech-appoints-patrik-stromberg-to-board-of-directors--enhancing-leadership-team,c4021181
New member of the board for a biotech startup Patrik Strömberg of AAX Biotech has over twenty years of expertise in the pharmaceutical sector with a strong foundation in business growth, innovation management, and research and development. Having held prominent roles at AstraZeneca and Biovitrum/Sobi, among other pharmaceutical businesses, he has a wealth of knowledge. Since 2021, Strömberg has served as AnaCardio's CEO. He graduated from Stockholm University with an MBA and Karolinska Institutet with a PhD in biochemistry. Experts from Stockholm, Sweden's Karolinska Institutet created AAX Biotech.
